DGCG

The NIH Annual Pain Consortium Symposium recently took place on the NIH campus. The annual meeting, which highlights current knowledge and advances in pain research supported by the NIH and other agencies, was particularly timely, as pain management and the use of pain medications is a topic that has gripped the nation over the past year. It’s more critical than ever that we find new ways to evaluate and manage pain.

ShareThis: 

Do you know the difference between an explanatory and a pragmatic clinical trial? Many researchers are familiar with explanatory clinical trials, which look at the effectiveness of a particular intervention to improve health in a controlled setting. But what makes a clinical trial pragmatic?

ShareThis: 

The Grant Support Index. At the moment, if you bring up these words around NIH, you are guaranteed an extended conversation, meetings that run long and late, and strong emotions bubbling throughout. I suspect much the same is happening on many campuses.

ShareThis: 

As you may know, the National Advisory Council on Aging met here in Bethesda last week. Among the many actions it took was the review and approval of seven new concepts for NIA Funding Opportunity Announcements (FOAs). You can find brief summaries of the cleared concepts on our website.

ShareThis: 

The wait was long—but the news is good! If you’ve been following events on Capitol Hill, you already know this. NIH has received a $2 billion increase in budget for this fiscal year, reflecting much-appreciated bipartisan support for biomedical research. NIA’s own budget received a monster $400 million boost for Alzheimer’s-related research, and our budget for other research areas increased at the same percentage rate as the NIH budget.

ShareThis: 

We’re excited about attending the annual meeting of the American Geriatrics Society (AGS) on May 18–20 in San Antonio. We hope you’re looking forward to exploring the River Walk and sampling some authentic Tex-Mex food. We also hope that you’ll take the opportunity to connect with NIA staff at the meeting, during scientific sessions, and at the Exhibit Hall.

ShareThis: 

Stem-cell therapies or stem-cell-targeted treatments are being used in clinics across the country to treat a variety of diseases and conditions. The 21st Century Cures Act, which was enacted in December2016, includes the Regenerative Medicine Initiative which will help us better understand how clinicians may use stem cells safely and effectively in therapy.

 

ShareThis: 

Did you know? NIA receives somewhere around 4,000 applications for funding in response to new and existing funding opportunity announcements (FOAs) each year. And, each application is reviewed. With that level of interest, you can imagine that we are always looking for investigators who are willing and able to serve as peer reviewers.

ShareThis: 

As readers of this blog surely know, NIA publishes Funding Opportunity Announcements (FOAs) in the NIH Guide to—you guessed it—announce new opportunities to apply for funding. We use FOAs to inform potential applicants of new initiatives ranging from traditional R01 research grants to large P50 center grants and national surveys. But have you stopped to think about where an FOA originates? Read on for a behind-the-scenes look at FOA development.

ShareThis: 

In mid-January, I attended the World Economic Forum annual meeting in Davos, Switzerland. This unique event—popularly referred to simply as Davos—connects international leaders in the private and public sectors—from government, business, and academia—to improve the global community. While “economics” is part of the meeting’s name, health, science, and technology were integral to the discussions.

ShareThis: 
Subscribe to RSS - DGCG